Venostent Completes $16M Series A Financing, Receives Ide Approval From Fda To Begin Us Trial
Amount Raised
$16 Million
Round Type
Series A
HoustonHealthcareInvestors
Description
HOUSTON, TX / July 31, 2023 / VenoStent, Inc., a clinical-stage, venture-backed, therapeutic medical device company developing bioabsorbable wraps to improve outcomes for hemodialysis patients, has announced that they have been granted Investigational Device Exemption (IDE) from the FDA for their US clinical trial, SAVE-FistulaS, and have completed a $16M Series A financing to fund these efforts.
Quick answer
VenoStent raised $16 Million in a Series A round, dated July 31, 2023. Investors: Texas Halo Fund, Health Wildcatters, Y Combinator, National Institute Of Health, National Science Foundation, Kidney X, Alumni Ventures and Cowtown Angels. VenoStent is based in Houston, Texas, United States.
- How much did VenoStent raise?
- VenoStent raised $16 Million in a Series A round on July 31, 2023.
- Who invested in VenoStent?
- Texas Halo Fund, Health Wildcatters, Y Combinator, National Institute Of Health, National Science Foundation, Kidney X, Alumni Ventures and Cowtown Angels are named as investors in this round.
- What does VenoStent do?
- VenoStent is a venture backed, clinical stage medical device and tissue engineering company that’s developed bioabsorbable polymer scaffolds in order to vastly improve vascular surgery outcomes.
- Where is VenoStent based and how big is it?
- VenoStent is based in Houston, Texas, United States. Fundz records about 36 employees.
- Who are the decision-makers at VenoStent?
- Fundz holds 1 contact at VenoStent. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as VenoStent that raised within 45 days of this round, from Fundz verified event records.
- Sonex Health, Inc. raised an undisclosed amount (Series B) on September 13, 2023.
- Summus Global raised $20M (Funding Round) on September 13, 2023.
- Elira, Inc. raised $2.1M (Seed) on September 13, 2023.
- Renibus Therapeutics raised an undisclosed amount (Series B) on September 12, 2023.
- Streamex Corp. raised $794K (Seed) on September 12, 2023.
- Vida Diagnostics raised $11M on September 12, 2023.
Who to call at VenoStent, and when
A new round usually means VenoStent is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day VenoStent raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at VenoStent, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at VenoStent. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment VenoStent raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansVenoStent raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.